Navigation Links
Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect to Charter Amendments
Date:7/8/2009

r 31, 2008 previously filed with the SEC. Additional information regarding the interests of those persons may be obtained by reading the proxy statement relating to the proposed amendments.

About Cornerstone Therapeutics

Cornerstone Therapeutics Inc. (Nasdaq CM: CRTX), headquartered in Cary, N.C., is a specialty pharmaceutical company focused on acquiring, developing and commercializing significant products primarily for the respiratory and related markets. The Company currently promotes multiple marketed products in the United States to respiratory-focused physicians and key retail pharmacies with its specialty sales force. The Company also has a late-stage clinical pipeline with five regulatory approval submissions targeted within the next three years. Key elements of the Company's strategy are to in-license or acquire rights to underpromoted, patent-protected, branded respiratory or related pharmaceutical products or late-stage product candidates; implement life cycle management strategies to maximize the potential value and competitive position of the Company's currently marketed products, newly acquired products and product candidates that are currently in development; grow product revenue through the Company's specialty sales force, which is focused on the respiratory and related markets; and maintain and strengthen the intellectual property position of the Company's currently marketed products, newly acquired products and product candidates.

Safe Harbor Statement

Statements in this press release regarding the progress and timing of our product development programs and related trials; our future opportunities; our strategy, future operations, financial position, future revenues and projected costs; our management's prospects, plans and objectives; and any other statements about management's future expectations, beliefs, goals, plans or prospects constitute forward-looki
'/>"/>

SOURCE Cornerstone Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
2. Cornerstone Therapeutics to Host Quarter and Year Ended December 31, 2008 Conference Call
3. Cornerstone Therapeutics Reports Year Ended December 31, 2008 Financial Results
4. Cornerstone Therapeutics to Present at BioCenturys 2009 Future Leaders in the Biotech Industry Conference
5. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
6. DJO Incorporateds Pending Merger With ReAble Therapeutics Clears U.S. Antitrust Review
7. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
8. Systems Medicine (SM), a Subsidiary of Cell Therapeutics, Inc. (CTI), Announces Execution of CRADA with NCI/NIH to Develop Potential Cancer Treatments Targeting the Insulin Growth Factor (IGF) Pathway
9. Amsterdam Molecular Therapeutics to Release H1 2007 Results on August 29, 2007
10. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
11. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... A new selection of laboratory ... is designed to meet the dynamic needs of ... new Cole-Parmer® MS-3400 Centrifuges are clinical ... They ensure a powerful and complete separation of ... standard four-place swinging buckets hold 50-mL tubes. With ...
(Date:5/16/2013)... 2013 Kitware , a ... announces new Phase II SBIR funding from the ... of an open-source, high performance computing (HPC) simulation ... enables researchers to select only the toolkits and ... computation, or analysis tasks. , Manufacturers increasingly ...
(Date:5/16/2013)... -- The registration deadline has been extended until May 22 ... Conference, the premier conference for bioscience financial officers. The ... San Diego Bayfront. "We are putting ... to make sure as many people as possible have ... , Chief Financial Officer of Mast Therapeutics, Inc. ...
(Date:5/16/2013)... 2013 As the weather warms, women everywhere ... Spring looks. While most make a statement with fashion, many ... find the warmer weather mixes makeup and sweat to produce, ... onset of acne during warmer months, Adult Acne treatment ... users the best ways to deter breakouts. , Recently, ...
Breaking Biology Technology:Cole-Parmer Offers Enhanced Selection of Centrifuges 2Kitware Develops a Customizable Simulation Framework to Provide HPC for Small to Mid-Sized Manufacturers 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Adult Acne Treatment, Probiotic Action Shares New Tips for Women on How to Fight Acne While Wearing Makeup 2
... Calif., May 21 AutoGenomics, a leader in developing ... team comprised of the Canada Research Chair in Medical ... new viruses and antiviral resistance, Professor Guy Boivin has ... for the presence of the new Flu A - ...
... giveaways show state,s growing germ-fighting focus ATLANTA, ... contingent to this week,s Biotechnology Industry Organization (BIO) ... they press the flesh with thousands of conference ... is distributing hundreds of containers of hand sanitizers ...
... (the "Company") (Nasdaq: KERX ) announced today the ... Company. It is also anticipated that Ron Bentsur will join ... the board on June 16, 2009.Michael P. Tarnok, Interim Chairman ... the Board, I want to welcome Ron Bentsur to Keryx. ...
Cached Biology Technology:AutoGenomics New RVP Assay Addresses Current Challenge to Detect Flu A - Swine H1N1 2BIO Visitors Bring Viral Preparedness to Atlanta 2BIO Visitors Bring Viral Preparedness to Atlanta 3Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer 2Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer 3Keryx Biopharmaceuticals Announces Appointment of Ron Bentsur as Chief Executive Officer 4
(Date:5/15/2013)... behavioral effects on diverse organisms often play large ... a theory proposed in the June issue of ... Ryan P. Ferrer of Seattle Pacific University and ... at Los Angeles, liken such molecules to keystone ... but exert a controlling influence, through predation or ...
(Date:5/15/2013)... of reducing greenhouse gas (GHG) emissions to 17 per ... federal and provincial governments, led by the Prime Minister ... of the total GHG reduction will be provided by ... School of the Environment. Their report is being ... parties and other participants in the climate policy dialogue. ...
(Date:5/15/2013)... strategic plan, " Forging the Future A Ten-Year ... Genome Institute (DOE JGI) has positioned itself to provide ... so that they can address pressing energy and environmental ... in this process is the launch of the ... of the ETOP is to develop and support selected ...
Breaking Biology News(10 mins):Natural 'keystone molecules' punch over their weight in ecosystems 2Canada must addess real climate-change challenge 2Canada must addess real climate-change challenge 3The DOE Joint Genome Institute expands capabilities via new partnerships 2The DOE Joint Genome Institute expands capabilities via new partnerships 3
... virus has a problem: it is a giant among viruses ... cell and reproduce. Professor Ari Helenius and Postdoc Jason Mercer ... this strategy is. In the process, they stumbled upon new ... In order to infiltrate a cell, the vaccinia virus ...
... a broad range of genetic tests. Paternity tests ... future baldness. With ongoing genetic discoveries and ... ever before and along with greater availability has ... How can consumers make informed decisions about genetic ...
... issues is the development of techniques that increase the ... 24, 2008 in the journal Vaccine, a Massachusettss biotechnology ... for anti-viral vaccination. This technology consists of two major ... two forms. One is easily processed within the organisms ...
Cached Biology News:A step forward in virology 2A step forward in virology 3American College of Medical Genetics makes genetic testing recommendations in new policy statement 2New technology for boosting vaccine efficiency 2New technology for boosting vaccine efficiency 3
Anti-BAR Immunogen: Peptide of aa 3-21 from human Bar Available Date: 38226...
... UbcH7 interacts with the HECT ... RING domain. Evidence suggests that ... both the degradation of non-""N-end ... certain N-a -acetylated proteins as ...
Anti-Mouse D011.10 TCR, Biotin (Clone KJ1-26) (mouse IgG2a)...
Reacts with methylated DNA from plants and vertebrates...
Biology Products: